Medicenna Therapeutics Corp. Key Management Personnel Compensation Share-based Payment
Medicenna Therapeutics Corp. (MDNAF) reported Key Management Personnel Compensation Share-based Payment of CAD 1.18 million for the 12-month period ending 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes › Compensation Related Costs
ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment · last filed 2023-06-27
| Period end | Key Management Personnel Compensation Share-based Payment 12 month |
|---|---|
| 2023-03-31 | 1.18M CAD 20-F · filed 2023-06-27 |
| 2022-03-31 | 886.00K CAD 20-F · filed 2023-06-27 |
| 2021-03-31 | 797.00K CAD 20-F · filed 2023-06-27 |
| 2020-03-31 | 873.00K CAD 20-F · filed 2022-06-22 |